Gut microbiome & melanoma
Gut microbiome & melanoma PRIMM (Predicting Response to Immunotherapy for Melanoma With Gut Microbiome and Metabolomics) is an international, collaborative study led by Dr Nathan, consultant dermatologist Dr [...]
Gut microbiome & melanoma PRIMM (Predicting Response to Immunotherapy for Melanoma With Gut Microbiome and Metabolomics) is an international, collaborative study led by Dr Nathan, consultant dermatologist Dr [...]
CTRT Support Forum Cancer can be an isolating experience; sometimes it can be difficult to find nearby support. Cancer Treatment and Research Trust has created a Support Forum [...]
Current opportunities in 2022 Cancer Treatment and Research Trust are reaching out to invite you to participate in exciting, once-in-a-lifetime opportunities! On the 6th October 2022, London [...]
Charitable structure update As of the 1st of January 2022, the Cancer Treatment and Research Trust are transitioning towards a new charitable structure and becoming a Charitable Incorporated [...]
New Cancer Therapies The Developmental Therapeutics Programme at the Hammersmith Hospital is a multi-disciplinary service established to care for patients with solid and haematologic malignancies who are looking [...]
Always on the move: Sarah's story Sarah is an inspiration to everyone around her. While I may have only conversed with her through a few [...]
Malignant Trophoblastic Disease Professor Michael Seckl Invasive Mole | Gestational Choriocarcinoma | Placental Site Trophoblastic Tumour Invasive Mole (Chorioadenoma destruens) Invasive mole is a [...]
Pre-Malignant Trophoblastic Disease Professor Michael Seckl Molar Pregnancy | Partial Mole | Complete Mole Molar Pregnancy The incidence of molar pregnancies in Europe and [...]